Last reviewed · How we verify

NCT03950466: RELIPOSA

Real Life Pediatric Obstructive Sleep Apnea

Status unknown Last updated 15 May 2019
What this trial tests

trial in Sleep Apnea, Obstructive in 1,200 participants. Status unknown.

Timeline
1 January 2018
Primary endpoint
31 January 2021
31 December 2023

Quick facts

Lead sponsorSociedad Española de Neumología y Cirugía Torácica
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,200
Start date1 January 2018
Primary completion31 January 2021
Estimated completion31 December 2023
Sites2 locations across Spain

Conditions studied

Sponsor

Sociedad Española de Neumología y Cirugía Torácica

Who can join

Adults 3 to 12, any sex, with Sleep Apnea, Obstructive or Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

OBJECTIVES: PRIMARY: To analyze the cognitive alterations in children with Obstructive Sleep Apnea OSA in different age groups and changes at 12 months after treatment with a protocol based on usual clinical practice. DESIGN: Observational, longitudinal, prospective, and multicenter study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sleep Apnea, Obstructive

Currently open trials in the same condition.

Other Sociedad Española de Neumología y Cirugía Torácica trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03950466.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing